Stimulating nerve growth with immunophilins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241841, 4242781, 514330, A61K 31435, A61K 3144

Patent

active

060807539

ABSTRACT:
Immunophilin ligands act by binding to receptor proteins, immunophilins, which in turn can bind to and regulate the Ca.sup.2+ dependent phosphatase, calcineurin, and the Ca.sup.2+ release channel, the ryanodine receptor. Immunophilin ligands have been discovered to enhance neurite outgrowth in neuronal cell systems by increasing sensitivity to neurotrophic factors. The effects of the immunophilin ligands are detected at subnanomolar concentrations indicating therapeutic application in diseases involving neural degeneration.

REFERENCES:
patent: 5100899 (1992-03-01), Calne
patent: 5321009 (1994-06-01), Baeder et al.
patent: 5330993 (1994-07-01), Armistead et al.
patent: 5614547 (1997-03-01), Hamilton et al.
Kitamura et al., J. Neuroimmunology, vol. 50, pp. 221-224, Mar., 1994.
Shiga et al., Brain Res., vol. 595, pp. 145-148, 1992.
Ryba et al., Acta Neurochirurgica, vol. 112, pp. 25-27, 1991.
Teichner et al. J. Hirnforschung, vol. 34, pp. 343-349, 1993.
Steiner et al., "Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerativ eanimal models", Proc. Natl. Acad. Sci. USA vol. 94 p. 2019-2024, Mar. 1997.
Steiner et al. "Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A" Nature Medicine, vol. 3 No. 4 Apr. 1997, pp. 421-428.
Lyons et al., "Immunosuppressant FK506 promotes neurite outgrowth in culture of PC12 cells and sensory ganglia", Proc. Natl Acad. Sci. USA, vol. 91, pp. 3191-3195, Apr. 1994.
Sharkey et al., "Immunophilins mediate the nueuroprotective effects of FK506 in focal cerebral ischemia" Nature, 371(6495), pp. 336-339.
Gold et al., "The immunosuppressant FK506 increase functional recovery and nerve regeneration following peripheral nerve injury", Restor. Neurol. Neurosci., 6(4) pp. 287-296.
Rajaofetra et al., Brain Research, vol. 572, pp. 329-334, 1992.
Tindall, J. Autoimmunity, vol. 5 (Suppl. A) pp. 301-313, 1992.
Lopez et al., Transplant Proceed., vol. 23, pp. 3181-3182, 1991.
Jackowski, Br. J. Neurosurgery, vol. 9, pp. 303-317, 1995.
Stteltenbung-Didinger et al., Neurotoxicology 13:179-184 (1992).
Appel et al., Srch Neurol. 45:381-386 (1988).
Lonfu et al. in Neurotrophic Factors, Loughin et al. (Acad. Press 1993) pp. 235-237.
Lindsey et al. Ibid., pp. 265-267.
Gold et al., "An Immunosuppressant Increases Functional Recovery and Axonal Regeneration in the Rat Following Axotomy of the Sciatic Nerve", Society for Neuroscience Abstracts, 19:543.18 (1993).
Stein et al., "Increased Expression of FK-506 Binding Protein During Peripheral Nerve Regeneration", Society for Neuroscience Abstracts 18:262.7 (1992).
Steiner et al., "The Immunosuppressant FK-506 Enhances Phosphorylation of GAP63: Implications for a Role in Modulation of Growth Cone Function and Neurotransmiter Release", Scoiety for Neuroscience Abstract, 18:262.8 (1992).
Lyons et al., "Immunosuppressant FK506 Promots Neurite Outgrowth in Cultures of PC12 Cells and Sensory Ganglia", Proc. Natl. Acad. Sci. USA, 91: to be released (1994).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Stimulating nerve growth with immunophilins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stimulating nerve growth with immunophilins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stimulating nerve growth with immunophilins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1785011

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.